↓ Skip to main content

Endocannabinoids

Overview of attention for book
Attention for Chapter 15: Endocannabinoids
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)

Mentioned by

twitter
6 tweeters
facebook
5 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
45 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Endocannabinoids
Chapter number 15
Book title
Endocannabinoids
Published in
Handbook of experimental pharmacology, January 2015
DOI 10.1007/978-3-319-20825-1_15
Pubmed ID
Book ISBNs
978-3-31-920824-4, 978-3-31-920825-1
Authors

Izzo, Angelo A, Muccioli, Giulio G, Ruggieri, Michael R, Schicho, Rudolf, Angelo A. Izzo, Giulio G. Muccioli, Michael R. Ruggieri, Rudolf Schicho, Izzo, Angelo A., Muccioli, Giulio G., Ruggieri, Michael R.

Editors

Roger G. Pertwee

Abstract

Components of the so-called endocannabinoid system, i.e., cannabinoid receptors, endocannabinoids, as well as enzymes involved in endocannabinoid synthesis and degradation, have been identified both in the gastrointestinal and in the urinary tract. Evidence suggests that the endocannabinoid system is implicated in many gastrointestinal and urinary physiological and pathophysiological processes, including epithelial cell growth, inflammation, analgesia, and motor function. A pharmacological modulation of the endocannabinoid system might be beneficial for widespread diseases such as gastrointestinal reflux disease, irritable bowel syndrome, inflammatory bowel disease, colon cancer, cystitis, and hyperactive bladder. Drugs that inhibit endocannabinoid degradation and raise the level of endocannabinoids, non-psychotropic cannabinoids (notably cannabidiol), and palmitoylethanolamide, an acylethanolamide co-released with the endocannabinoid anandamide, are promising candidates for gastrointestinal and urinary diseases.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Canada 1 2%
Unknown 43 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 18%
Other 7 16%
Researcher 7 16%
Student > Master 6 13%
Student > Bachelor 6 13%
Other 5 11%
Unknown 6 13%
Readers by discipline Count As %
Medicine and Dentistry 9 20%
Biochemistry, Genetics and Molecular Biology 6 13%
Agricultural and Biological Sciences 5 11%
Psychology 4 9%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Other 6 13%
Unknown 12 27%

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 August 2018.
All research outputs
#2,274,224
of 14,406,921 outputs
Outputs from Handbook of experimental pharmacology
#88
of 442 outputs
Outputs of similar age
#52,092
of 263,477 outputs
Outputs of similar age from Handbook of experimental pharmacology
#1
of 3 outputs
Altmetric has tracked 14,406,921 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 442 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 263,477 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them